Eisai, Biogen start U.S. accelerated approval for new Alzheimer’s drug, Health News, ET HealthWorld
By Julie Steenhuysen CHICAGO: Japanese drugmaker Eisai Co on Monday began its application process for its experimental drug for early Alzheimer’s disease using an accelerated approval pathway, the same path…
